Ligand validation:3VVR

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 3VVR designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3VVR_OLC_A_503	21%	66%	0.218	0.876	0.69	0.61	1	-	1	0	72%	1
3VVR_OLC_A_501	19%	65%	0.222	0.865	0.7	0.66	1	-	0	0	72%	1
3VVR_OLC_A_502	11%	62%	0.229	0.834	0.82	0.63	1	-	0	0	52%	1
3W4T_OLC_A_502	35%	51%	0.174	0.864	0.89	1	1	2	1	0	100%	1
3WBN_OLC_A_501	21%	60%	0.191	0.894	0.86	0.67	1	-	1	0	48%	1
3VVN_OLC_A_504	21%	85%	0.223	0.954	0.24	0.49	-	-	0	0	32%	1
3VVO_OLC_A_508	18%	85%	0.159	0.862	0.25	0.48	-	-	0	0	36%	1
3VVS_OLC_A_502	13%	56%	0.222	0.888	1.11	0.61	1	-	0	0	32%	1
9F9J_OLC_A_307	100%	42%	0.034	0.981	1.05	1.18	1	2	0	0	100%	1
7YXA_OLC_A_2505	70%	60%	0.127	0.943	0.67	0.84	-	-	3	0	100%	1
9F9D_OLC_A_308	67%	42%	0.081	0.887	0.96	1.29	1	3	0	0	100%	1
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	4	0	100%	1
4N6H_OLC_A_1222	63%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.